-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Ionis Pharmaceuticals, Lowers Price Target to $80

Benzinga·11/10/2026 15:12:03
Listen to the news
Wells Fargo analyst Yanan Zhu maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and lowers the price target from $95 to $80.